{"meta":{"query_hash":"8a888064ae0e","filters":{"venue":"Hematologic malignancies"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8a888064ae0e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Hematologic+malignancies"},"results":[{"id":"W2127646700","doi":"10.1007/978-3-319-12505-3_24","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2014,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Internal medicine; Malignancy; Lung cancer; Oncology; Relative risk; Population; Absolute risk reduction; Radiation therapy","score_opus":0.01940116088779189,"score_gpt":0.23645098463569467,"score_spread":0.21704982374790277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127646700","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09546359,0.031040955,0.00013086697,0.00016111253,0.0006398554,0.0016592834,0.0010816529,0.0002194431,0.8696032],"genre_scores_gemma":[0.27649102,0.007248392,0.0013236523,0.0007282478,0.00028926387,0.00022047112,0.00026951017,0.00014823665,0.7132812],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719363,0.0000494429,0.0010215234,0.00080547493,0.00042082192,0.0005091248],"domain_scores_gemma":[0.99743956,0.00019620427,0.0008395495,0.0011095626,0.00018982502,0.00022528855],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014829684,0.00083681865,0.0022751233,0.00028881687,0.00007978664,0.000017384436,0.00016282672,0.00075409363,0.01609021],"category_scores_gemma":[0.00004038171,0.0006333503,0.0008251232,0.000045908877,0.00040018465,0.000047707344,0.00007347845,0.00015825688,0.00034494395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012360562,0.0025233594,0.07949721,0.030151764,0.011340353,0.01791572,0.0069286358,0.000009762275,0.0048532286,0.38677692,0.120676465,0.32696602],"study_design_scores_gemma":[0.004285212,0.002477501,0.005496393,0.0013867255,0.0011129108,0.001060825,0.00005028182,0.000015202074,0.007545707,0.00453376,0.9710991,0.0009363891],"about_ca_topic_score_codex":0.000031997562,"about_ca_topic_score_gemma":0.00007262198,"teacher_disagreement_score":0.8504226,"about_ca_system_score_codex":0.00033265687,"about_ca_system_score_gemma":0.00040853056,"threshold_uncertainty_score":0.9996118},"labels":[],"label_agreement":null},{"id":"W3094050214","doi":"10.1007/978-3-030-57317-1_2","title":"Antibacterial and Antiparasitic Prophylaxis","year":2020,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hematological malignancy; Intensive care medicine; Antimicrobial; Immunosuppression; Mortality rate; Adverse effect; Internal medicine","score_opus":0.028139573608117377,"score_gpt":0.253014325127207,"score_spread":0.22487475151908964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094050214","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058688253,0.0036646284,0.00003949983,0.0018975186,0.00085678743,0.0013617104,0.00012538463,0.00044183232,0.9329244],"genre_scores_gemma":[0.7944964,0.0014000718,0.00034390105,0.0011772884,0.0005291902,0.000042904117,0.000057990663,0.00008459344,0.20186765],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987541,0.00001147381,0.00032773623,0.00048391896,0.00020034122,0.00022246774],"domain_scores_gemma":[0.99927217,0.000036320078,0.00015473698,0.0002824114,0.00008780514,0.00016656026],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044075965,0.00035500387,0.00086646597,0.000092840564,0.00010776989,0.000041295953,0.00007058709,0.00034195706,0.001128374],"category_scores_gemma":[0.00003868147,0.00028207994,0.00015796698,0.000037605078,0.00027080483,0.00004407542,0.000083663464,0.0003356615,0.00029043114],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005841902,0.00010482984,0.0067684446,0.0053631775,0.00056576054,0.0046585365,0.00027697458,1.7308709e-7,0.032881923,0.9267654,0.018903764,0.003126857],"study_design_scores_gemma":[0.00311564,0.0041941726,0.008941012,0.003325447,0.0015812942,0.01513131,0.000082864586,0.000004497557,0.016387466,0.030844605,0.9144493,0.0019424143],"about_ca_topic_score_codex":0.00000431634,"about_ca_topic_score_gemma":0.0000030464366,"teacher_disagreement_score":0.89592075,"about_ca_system_score_codex":0.000034073502,"about_ca_system_score_gemma":0.00014109453,"threshold_uncertainty_score":0.99996316},"labels":[],"label_agreement":null},{"id":"W4233452951","doi":"10.1007/978-3-030-32482-7_26","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2020,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hodgkin lymphoma; Medicine; Malignancy; Lymphoma; Oncology; Internal medicine","score_opus":0.02560708882478763,"score_gpt":0.23870812350478146,"score_spread":0.21310103467999383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233452951","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051340662,0.04366722,0.00004462043,0.00046752614,0.0005500999,0.0019231259,0.0020551055,0.00027019964,0.89968145],"genre_scores_gemma":[0.3766647,0.013727988,0.00232439,0.0018596599,0.0004413483,0.00032315622,0.00051903975,0.00023724807,0.60390246],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726385,0.000038516122,0.0009908477,0.00085196097,0.00042139157,0.00043345694],"domain_scores_gemma":[0.9978385,0.00014350335,0.00074189797,0.00084268796,0.0001550845,0.0002783369],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007972428,0.0008213217,0.0022266437,0.00020946783,0.000070732734,0.000017424258,0.0001615862,0.00064894155,0.015204717],"category_scores_gemma":[0.000041891184,0.0006362433,0.0008394125,0.000060737413,0.00034584574,0.00006658741,0.0000885922,0.00018087718,0.00037404455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022146104,0.0035341855,0.076947294,0.041197643,0.017758323,0.06616707,0.013815235,0.000008532846,0.009878968,0.3712642,0.16617623,0.21110623],"study_design_scores_gemma":[0.0050690887,0.0033401514,0.004853304,0.0013579392,0.0014806543,0.0011261714,0.000120009965,0.000018111494,0.012263624,0.006172257,0.96307796,0.0011207412],"about_ca_topic_score_codex":0.000023115195,"about_ca_topic_score_gemma":0.000041948388,"teacher_disagreement_score":0.7969017,"about_ca_system_score_codex":0.00032130413,"about_ca_system_score_gemma":0.000547285,"threshold_uncertainty_score":0.9996089},"labels":[],"label_agreement":null}]}